Cargando…

Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study

BACKGROUND: Multimorbidity is a global health problem that is usually associated with polypharmacy, which increases the risk of potentially inappropriate prescribing (PIP). PIP entails higher hospitalization rates and mortality and increased usage of services provided by the health system. Tools exi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogero-Blanco, Eloisa, Lopez-Rodriguez, Juan A, Sanz-Cuesta, Teresa, Aza-Pascual-Salcedo, Mercedes, Bujalance-Zafra, M Jose, Cura-Gonzalez, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078622/
https://www.ncbi.nlm.nih.gov/pubmed/32149715
http://dx.doi.org/10.2196/14130
_version_ 1783507658612932608
author Rogero-Blanco, Eloisa
Lopez-Rodriguez, Juan A
Sanz-Cuesta, Teresa
Aza-Pascual-Salcedo, Mercedes
Bujalance-Zafra, M Jose
Cura-Gonzalez, Isabel
author_facet Rogero-Blanco, Eloisa
Lopez-Rodriguez, Juan A
Sanz-Cuesta, Teresa
Aza-Pascual-Salcedo, Mercedes
Bujalance-Zafra, M Jose
Cura-Gonzalez, Isabel
author_sort Rogero-Blanco, Eloisa
collection PubMed
description BACKGROUND: Multimorbidity is a global health problem that is usually associated with polypharmacy, which increases the risk of potentially inappropriate prescribing (PIP). PIP entails higher hospitalization rates and mortality and increased usage of services provided by the health system. Tools exist to improve prescription practices and decrease PIP, including screening tools and explicit criteria that can be applied in an automated manner. OBJECTIVE: This study aimed to describe the prevalence of PIP in primary care consultations among patients aged 65-75 years with multimorbidity and polypharmacy, detected by an electronic clinical decision support system (ECDSS) following the 2015 American Geriatrics Society Beers Criteria, the European Screening Tool of Older Person’s Prescription (STOPP), and the Screening Tool to Alert doctors to Right Treatment (START). METHODS: This was an observational, descriptive, cross-sectional study. The sample included 593 community-dwelling adults aged 65-75 years (henceforth called young seniors), with multimorbidity (≥3 diseases) and polypharmacy (≥5 medications), who had visited their primary care doctor at least once over the last year at 1 of the 38 health care centers participating in the Multimorbidity and Polypharmacy in Primary Care (Multi-PAP) trial. Sociodemographic data, clinical and pharmacological treatment variables, and PIP, as detected by 1 ECDSS, were recorded. A multivariate logistic regression model with robust estimators was built to assess the factors affecting PIP according to the STOPP criteria. RESULTS: PIP was detected in 57.0% (338/593; 95% CI 53-61) and 72.8% (432/593; 95% CI 69.3-76.4) of the patients according to the STOPP criteria and the Beers Criteria, respectively, whereas 42.8% (254/593; 95% CI 38.9-46.8) of the patients partially met the START criteria. The most frequently detected PIPs were benzodiazepines (BZD) intake for more than 4 weeks (217/593, 36.6%) using the STOPP version 2 and the prolonged use of proton pump inhibitors (269/593, 45.4%) using the 2015 Beers Criteria. Being a woman (odds ratio [OR] 1.43, 95% CI 1.01-2.01; P=.04), taking a greater number of medicines (OR 1.25, 95% CI 1.14-1.37; P<.04), working in the primary sector (OR 1.91, 95% CI 1.25-2.93; P=.003), and being prescribed drugs for the central nervous system (OR 3.75, 95% CI 2.45-5.76; P<.001) were related to a higher frequency of PIP. CONCLUSIONS: There is a high prevalence of PIP in primary care as detected by an ECDSS in community-dwelling young seniors with comorbidity and polypharmacy. The specific PIP criteria defined by this study are consistent with the current literature. This ECDSS can be useful for supervising prescriptions in primary health care consultations.
format Online
Article
Text
id pubmed-7078622
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-70786222020-03-25 Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study Rogero-Blanco, Eloisa Lopez-Rodriguez, Juan A Sanz-Cuesta, Teresa Aza-Pascual-Salcedo, Mercedes Bujalance-Zafra, M Jose Cura-Gonzalez, Isabel JMIR Med Inform Original Paper BACKGROUND: Multimorbidity is a global health problem that is usually associated with polypharmacy, which increases the risk of potentially inappropriate prescribing (PIP). PIP entails higher hospitalization rates and mortality and increased usage of services provided by the health system. Tools exist to improve prescription practices and decrease PIP, including screening tools and explicit criteria that can be applied in an automated manner. OBJECTIVE: This study aimed to describe the prevalence of PIP in primary care consultations among patients aged 65-75 years with multimorbidity and polypharmacy, detected by an electronic clinical decision support system (ECDSS) following the 2015 American Geriatrics Society Beers Criteria, the European Screening Tool of Older Person’s Prescription (STOPP), and the Screening Tool to Alert doctors to Right Treatment (START). METHODS: This was an observational, descriptive, cross-sectional study. The sample included 593 community-dwelling adults aged 65-75 years (henceforth called young seniors), with multimorbidity (≥3 diseases) and polypharmacy (≥5 medications), who had visited their primary care doctor at least once over the last year at 1 of the 38 health care centers participating in the Multimorbidity and Polypharmacy in Primary Care (Multi-PAP) trial. Sociodemographic data, clinical and pharmacological treatment variables, and PIP, as detected by 1 ECDSS, were recorded. A multivariate logistic regression model with robust estimators was built to assess the factors affecting PIP according to the STOPP criteria. RESULTS: PIP was detected in 57.0% (338/593; 95% CI 53-61) and 72.8% (432/593; 95% CI 69.3-76.4) of the patients according to the STOPP criteria and the Beers Criteria, respectively, whereas 42.8% (254/593; 95% CI 38.9-46.8) of the patients partially met the START criteria. The most frequently detected PIPs were benzodiazepines (BZD) intake for more than 4 weeks (217/593, 36.6%) using the STOPP version 2 and the prolonged use of proton pump inhibitors (269/593, 45.4%) using the 2015 Beers Criteria. Being a woman (odds ratio [OR] 1.43, 95% CI 1.01-2.01; P=.04), taking a greater number of medicines (OR 1.25, 95% CI 1.14-1.37; P<.04), working in the primary sector (OR 1.91, 95% CI 1.25-2.93; P=.003), and being prescribed drugs for the central nervous system (OR 3.75, 95% CI 2.45-5.76; P<.001) were related to a higher frequency of PIP. CONCLUSIONS: There is a high prevalence of PIP in primary care as detected by an ECDSS in community-dwelling young seniors with comorbidity and polypharmacy. The specific PIP criteria defined by this study are consistent with the current literature. This ECDSS can be useful for supervising prescriptions in primary health care consultations. JMIR Publications 2020-03-03 /pmc/articles/PMC7078622/ /pubmed/32149715 http://dx.doi.org/10.2196/14130 Text en ©Eloisa A Rogero-Blanco, Juan A Lopez-Rodriguez, Teresa Sanz-Cuesta, Mercedes Aza-Pascual-Salcedo, M Jose Bujalance-Zafra, Isabel Cura-Gonzalez, MultiPAP Group. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 03.03.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on http://medinform.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Rogero-Blanco, Eloisa
Lopez-Rodriguez, Juan A
Sanz-Cuesta, Teresa
Aza-Pascual-Salcedo, Mercedes
Bujalance-Zafra, M Jose
Cura-Gonzalez, Isabel
Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study
title Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study
title_full Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study
title_fullStr Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study
title_full_unstemmed Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study
title_short Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study
title_sort use of an electronic clinical decision support system in primary care to assess inappropriate polypharmacy in young seniors with multimorbidity: observational, descriptive, cross-sectional study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078622/
https://www.ncbi.nlm.nih.gov/pubmed/32149715
http://dx.doi.org/10.2196/14130
work_keys_str_mv AT rogeroblancoeloisa useofanelectronicclinicaldecisionsupportsysteminprimarycaretoassessinappropriatepolypharmacyinyoungseniorswithmultimorbidityobservationaldescriptivecrosssectionalstudy
AT lopezrodriguezjuana useofanelectronicclinicaldecisionsupportsysteminprimarycaretoassessinappropriatepolypharmacyinyoungseniorswithmultimorbidityobservationaldescriptivecrosssectionalstudy
AT sanzcuestateresa useofanelectronicclinicaldecisionsupportsysteminprimarycaretoassessinappropriatepolypharmacyinyoungseniorswithmultimorbidityobservationaldescriptivecrosssectionalstudy
AT azapascualsalcedomercedes useofanelectronicclinicaldecisionsupportsysteminprimarycaretoassessinappropriatepolypharmacyinyoungseniorswithmultimorbidityobservationaldescriptivecrosssectionalstudy
AT bujalancezaframjose useofanelectronicclinicaldecisionsupportsysteminprimarycaretoassessinappropriatepolypharmacyinyoungseniorswithmultimorbidityobservationaldescriptivecrosssectionalstudy
AT curagonzalezisabel useofanelectronicclinicaldecisionsupportsysteminprimarycaretoassessinappropriatepolypharmacyinyoungseniorswithmultimorbidityobservationaldescriptivecrosssectionalstudy
AT useofanelectronicclinicaldecisionsupportsysteminprimarycaretoassessinappropriatepolypharmacyinyoungseniorswithmultimorbidityobservationaldescriptivecrosssectionalstudy